{"id": "1329047272256983043", "creation": 1605704536.0, "user_id": "1239804453307342849", "social_network": "twitter", "nsfw": false, "request": ["1aac5aa9-16ef-4aef-93e1-0b43ea7d03cb"], "metrics": {"1aac5aa9-16ef-4aef-93e1-0b43ea7d03cb": {"retweet_count": 1, "reply_count": 1, "like_count": 1, "quote_count": 0}}, "quoted": "1329037462547607552", "text": "Extremely excited that @AKUGlobal have recruited their first participant into the #COPCOV study. The world\u2019s largest #COVID19 prophylaxis clinical trial. #chloroquine @MartinLlewelyn @TropMedOxford https://t.co/GYSUouqg4c", "first_save": 1635413522.816877, "hashtags": ["#COPCOV", "#COVID19", "#CHLOROQUINE"]}